Many biotech and pharmaceutical companies find themselves in a “good news–bad news” situation: Positive late-phase clinical data and a potentially registrational product, but little or no prior investment in establishing a Medical Affairs function.
This webinar explored how to build a Medical Affairs organization from scratch and accelerate its development into a high-performing, launch-ready team. Participants learned how Medical Affairs can support the 4As of Approval, Access, Advocacy, and Adoption while focusing on the 3Ps: Preparing the Product, Preparing the Market, and Preparing the Company.
Attendees gained practical insights into capability building, organizational design, prioritization, and execution, enabling Medical Affairs to move rapidly from foundational activities to delivering strategic impact.

Partner Circle Program
Speakers

Executive Vice President, Medical Strategy
Lumanity

Head of Medical Affairs Oncology, EU & Canada
Daiichi Sankyo Europe GmbH

Senior Vice President, Head of Medical Affairs
Apellis Pharmaceuticals